Sonoma Pharmaceuticals
SNOA
#10631
Rank
C$5.46 M
Marketcap
C$1.57
Share price
2.70%
Change (1 day)
-64.64%
Change (1 year)

Earnings for Sonoma Pharmaceuticals (SNOA)

Earnings in 2025 (TTM): -C$4.39 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings are C$16.93 Million. In 2024 the company made an earning of -C$6.16 Million a decrease over its 2023 earnings that were of -C$6.13 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sonoma Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$4.39 Million-28.79%
2024 -C$6.16 Million0.54%
2023 -C$6.13 Million-31.5%
2022 -C$8.94 Million16.86%
2021 -C$7.65 Million194.32%
2020 -C$2.6 Million-58.76%
2019 -C$6.3 Million-65.66%
2018 -C$18.35 Million4.84%
2017 -C$17.5 Million-2.17%
2016 -C$17.89 Million32.12%
2015 -C$13.54 Million-307.74%
2014 C$6.51 M-197.5%
2013 -C$6.69 Million
2010 -C$10.45 Million-14.02%
2009 -C$12.15 Million-57.28%
2008 -C$28.44 Million-8.03%
2007 -C$30.92 Million3.85%
2006 -C$29.77 Million39.31%
2005 -C$21.37 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-C$0.22 Billion 5,013.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-C$25.04 Million 482.11%๐Ÿ‡บ๐Ÿ‡ธ USA